Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
9.60
+0.26 (2.78%)
At close: Aug 25, 2026, 4:00 PM EDT
9.75
+0.15 (1.56%)
After-hours: Aug 25, 2026, 7:30 PM EDT

Arvinas Revenue

Arvinas had revenue of $249.70M in the quarter ending June 30, 2026, with 1,014.73% growth. This brings the company's revenue in the last twelve months to $316.70M, down -15.05% year-over-year. In the year 2025, Arvinas had annual revenue of $262.60M, down -0.30%.

Revenue (ttm)
$316.70M
Revenue Growth
-15.05%
P/S Ratio
1.98
Revenue / Employee
$1,287,398
Employees
246
Market Cap
627.71M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025262.60M-800.00K-0.30%
Dec 31, 2024263.40M184.90M235.54%
Dec 31, 202378.50M-52.90M-40.26%
Dec 31, 2022131.40M77.80M145.15%
Dec 31, 202153.60M27.70M106.95%
Dec 31, 202025.90M-17.10M-39.77%
Dec 31, 201943.00M28.68M200.20%
Dec 31, 201814.32M6.75M89.00%
Dec 31, 20177.58M909.85K13.64%
Dec 31, 20166.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CorMedix462.25M
MiMedx Group355.17M
Autolus Therapeutics117.39M
Verastem87.53M
OmniAb38.46M
Scribe Therapeutics36.28M
Prime Medicine4.07M
Altimmune31.00K
Revenue Rankings